SUGARLO PLUS 30TAB

each tablet contains : vildagliptin 50 mg .

74.25 EGP

Purchase this product now and earn 74 Points!

SUGARLO PLUS 30TAB; metformin, vildagliptin, blood glucose regulators .

ACTIVE-INGREDIENT OF SUGARLO PLUS 30TAB

each tablet contains : vildagliptin 50 mg .

INDICATION OF SUGARLO PLUS 30TAB

vildagliptin is indicated in the treament of typy 2 diabetes mellitus in adults : as monotherapy : in patients inadequately contrrolled by diet and exercise exercise alone and for whom meltformin is inappropriate due to contraindications or intolerance . as dual oral therapy in combination with : metformin , in patients with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin . a sulphonylurea , in patients with insufficient glycaemic control despite maximal tolerated dose of a sulphonylurea and for whom metformin is inappropriate due to contraindications and intolerance . a thiazolidinedione , in patients with insufficient glycaemic control and cfor whom the use of a thiazolidendione is appropriate . as triple oral therapy in combination with : a sulphonylurea and metformin when diet and excercise plus dual therapy with these medicinal products do not provide adequate glycaemic control . vildagliptin is also indicated for use in combination with insulin ( withor without metformin ) when diet and exercise plus a stable dose of insulin do not provide adequate glycaemic contol

DOSAGE OF SUGARLO PLUS 30TAB

Follow all directions given to you by your pharmacist or doctor carefully . They may differ from the information contained in this leaflet

Ask your pharmacist or doctor for help if you do not understand the instructions on the box .

The recommended dose is : –

adults : when used as monotherapy , in combination with thiazolidedione daily dose vildagliptin is 100 mg , administred with a sulphonylurea , the recommended dose of vildaglipitin is 50 mg once daily administered in the morning . In this patient population , vildagliptin 100 mg daily was no more effective than vildagliptin 50 mg once daily . when used in combination with a sulphonylurea , a lower dose of the sulphonylurea may be considered to reduce the risk of hypoglycaemia . doses higher than 100 mg are not recommended . if doses higher than 100 mg are not recommended . if a dose of sugario is missed , it should be taken as soon as the patient remembers . a double dose should not be taken on the same day . the safety and efficacy of vildagliptin as triple oral therapy in combination with metformin and a thiazolidinedione have not been established . additional information on special populations : elderly (≥ 65 years ) : no dose adjustments are necessary in elderly patients . renal impairment : no dose adjustment is required in patients with mild renal impairment ( creatinine clearance ≥ 50 ml/min ) in patients with moderate or severe renal impairment or with end-stage renal disease (ESRD) THE RECOMMENDED for use in children and adolescents ( OVER-DOSAGE OF SUGARLO PLUS 30TAB

CONTRA-INDICATION OF SUGARLO PLUS 30TAB

hypersensitivity to the active substance or to any of the excipients .

STORAGE OF SUGARLO PLUS 30TAB

keep out of reach of children , stored at temperature not exceeding 30 C , in dry place .
PACK OF SUGARLO PLUS 30TAB
carton box contain one strip or 3 strips 10 10 tablets .
SUGARLO PLUS 30TAB MANUFACTURED BY
AL-ESRAA PHAMJACEUTICAL OPTIMAL .

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515409/

https://en.wikipedia.org/wiki/Vildagliptin#:~:text=Vildagliptin%20(trade%20name%20Galvus)%20is,4)%20inhibitor%20class%20of%20drugs.

https://www.gardeniapharmacy.com/category/medicine-2/

Form

Gender

How to use

Reviews

There are no reviews yet.

Show reviews in all languages (1)

Be the first to review “SUGARLO PLUS 30TAB”

Your email address will not be published.

Shopping Cart
Don`t copy text!
Scroll to Top